Recital 7, Regulation (EU) 2021/525

In forcesince 19 Oct 2020cited 1×

Point 6 of Title 1 of Annexes II and III set out the requirements for the assessment of the effectiveness of an active substance or a biocidal product, respectively, against target organisms. Such effectiveness should also be demonstrated for the activity of an active substance in the absence of other substances that may affect the effectiveness. For treated articles, the effectiveness of the biocidal properties conferred to the article should be demonstrated. Moreover, the current provisions on unintended side-effects in point 6 do not specify on which type of organisms or objects information should be provided. Therefore, it should be clarified that any observation on undesirable or unintended side effects is to be limited to non-target organisms or objects and material to be protected by the active substance or biocidal product.

  • Judgment of the General Court (Seventh Chamber) of 16 November 2022 (Extracts). Sciessent LLC v European Commission.Decision

    That principle is now set out in recital 7 of Delegated Regulation 2021/525. That recital states that for treated articles, the efficacy of the biocidal properties imparted on the article should be demonstrated.

    16 Nov 2022 · 62020TJ0122